A study to assess the bioavailability and to compare the pharmacokinetics of AZD7594 inhaled via monodose inhaler and multiple-dose dry powder inhalers (DPI) or pressurized metered-dose inhaler (pMDI) in healthy male subjects

Trial Identifier: D3741C00004
Sponsor: AstraZeneca
NCTID:: NCT02648438
Start Date: January 2016
Primary Completion Date: June 2016
Study Completion Date: June 2016
Condition: Asthma; Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, MD Baltimore, MD, United States of America